Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Sungen Biomedical Technology Co., Ltd

Clinical trials sponsored by Beijing Sungen Biomedical Technology Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New injection could save heart muscle after attack Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Completed 2

Can a single infusion prevent organ failure in severe pancreatitis?

Disease control Not yet recruiting

This trial tests an experimental drug called SGC001 in people who are likely to develop severe acute pancreatitis, a painful inflammation of the pancreas that can lead to organ failure. Participants receive either SGC001 or a placebo as a single intravenous infusion alongside sta…

Phase 2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Sep 06, 2026 00:00 UTC